Cargando…
Exome sequencing circumvents missing clinical data and identifies a BSCL2 mutation in congenital lipodystrophy
BACKGROUND: Exome sequencing has become more and more affordable and the technique has emerged as an important diagnostic tool for monogenic disorders at early stages of investigations, in particular when clinical information is limited or unspecific as well as in cases of genetic heterogeneity. MET...
Autores principales: | Schuster, Jens, Khan, Tahir Naeem, Tariq, Muhammad, Shaiq, Pakeeza Arzoo, Mäbert, Katrin, Baig, Shahid Mahmood, Klar, Joakim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076434/ https://www.ncbi.nlm.nih.gov/pubmed/24961962 http://dx.doi.org/10.1186/1471-2350-15-71 |
Ejemplares similares
-
Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family
por: Rahman, Obaid Ur, et al.
Publicado: (2013) -
Whole Exome Sequencing Reveals a BSCL2 Mutation Causing Progressive Encephalopathy with Lipodystrophy (PELD) in an Iranian Pediatric Patient
por: Alaei, Mohammad Reza, et al.
Publicado: (2016) -
Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy
por: Mcilroy, George D., et al.
Publicado: (2020) -
Novel compound heterozygous variant of BSCL2 identified by whole exome sequencing and multiplex ligation-dependent probe amplification in an infant with congenital generalized lipodystrophy
por: Xie, Bobo, et al.
Publicado: (2020) -
The Human Lipodystrophy Gene BSCL2/Seipin May Be Essential for Normal Adipocyte Differentiation
por: Payne, Victoria A., et al.
Publicado: (2008)